Rion Inc.: Clinical Trials

4 trials sponsored by Rion Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting. 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Unknown 2, Not yet recruiting 1
Phase 22Completed 1, Not yet recruiting 1

Follow Rion Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer
PEP-TISSEEL, TISSEEL Fibrin Sealant KIT - Chronic Radiation Ulcer
Phase 1 / Phase 2Not yet recruitingRion Inc.1842025-06-012025-04-06
Phase 1b Clinical Trial to Evaluate PEP and EUFLEXXA for Knee Osteoarthritis (KOA)
PEP/Euflexxa, PEP - Knee Osteoarthritis
Phase 1UnknownRion Inc.242024-11-012024-06-17
Phase 2a Multi-Center Prospective, Randomized Trial to Evaluate the Safety & Efficacy of Topical PEP-TISSEEL for Diabetic Foot Ulcers (DFU)
PEP (Purified Exosome Product) / TISSEEL - Diabetic Foot Ulcer
Phase 2CompletedRion Inc.592024-02-272026-07-20
PEP on a Skin Graft Donor Site Wound
10% PEP, TISSEEL, 20% PEP - Skin Graft
Phase 1UnknownRion Inc.82021-03-162023-09-08

Conditions studied

Arthritis (1)  ·  Diabetic Foot (1)  ·  Foot Ulcer (1)  ·  Joint Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)  ·  Rheumatic Diseases (1)  ·  Wounds and Injuries (1)

Interventions

Fibrin Tissue Adhesive (2)

Countries

United States (4)

Top investigators

Michael Sabbah, MD (1)  ·  Patrick Walker, MD (1)